AU2590099A - Protein folding inhibitors - Google Patents
Protein folding inhibitorsInfo
- Publication number
- AU2590099A AU2590099A AU25900/99A AU2590099A AU2590099A AU 2590099 A AU2590099 A AU 2590099A AU 25900/99 A AU25900/99 A AU 25900/99A AU 2590099 A AU2590099 A AU 2590099A AU 2590099 A AU2590099 A AU 2590099A
- Authority
- AU
- Australia
- Prior art keywords
- protein folding
- folding inhibitors
- inhibitors
- protein
- folding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7407098P | 1998-02-09 | 1998-02-09 | |
US60074070 | 1998-02-09 | ||
PCT/US1999/002612 WO1999040435A1 (en) | 1998-02-09 | 1999-02-06 | Protein folding inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2590099A true AU2590099A (en) | 1999-08-23 |
Family
ID=22117530
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU25900/99A Abandoned AU2590099A (en) | 1998-02-09 | 1999-02-06 | Protein folding inhibitors |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2590099A (en) |
WO (1) | WO1999040435A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6274597B1 (en) | 1998-06-01 | 2001-08-14 | Mount Sinai School Of Medicine Of New York University | Method of enhancing lysosomal α-Galactosidase A |
EP1141708A1 (en) * | 1998-12-28 | 2001-10-10 | Sunesis Pharmaceuticals Inc. | Identifying small organic molecule ligands for binding |
IL137905A0 (en) * | 2000-08-16 | 2001-10-31 | Nathan Citri | Direct selection of protein complexes relevant to the physiological or diagnostic context of a biological specimen |
EP1746422A1 (en) * | 2005-07-19 | 2007-01-24 | Universita'degli Studi Di Milano | Method for the identification of proteins folding inhibitors |
WO2007094391A1 (en) * | 2006-02-17 | 2007-08-23 | Kwansei Gakuin Educational Foundation | Method for suppressing gene expression utilizing interdomain interaction |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5679582A (en) * | 1993-06-21 | 1997-10-21 | Scriptgen Pharmaceuticals, Inc. | Screening method for identifying ligands for target proteins |
US5585277A (en) * | 1993-06-21 | 1996-12-17 | Scriptgen Pharmaceuticals, Inc. | Screening method for identifying ligands for target proteins |
-
1999
- 1999-02-06 AU AU25900/99A patent/AU2590099A/en not_active Abandoned
- 1999-02-06 WO PCT/US1999/002612 patent/WO1999040435A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1999040435A1 (en) | 1999-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2434199A (en) | Protein | |
AU2001232799A1 (en) | Protein c derivatives | |
AU6411698A (en) | Substituted 2-anilinopyrimidines useful as protein kinase inhibitors | |
AU5395299A (en) | Modified soy protein adhesives | |
AU1550300A (en) | Antigen-binding proteins | |
AU6045900A (en) | Interaction-activated proteins | |
AU6882598A (en) | Protein kinase inhibitor | |
AU3350800A (en) | Protein sweetener | |
AU5587799A (en) | Protein transport-associated molecules | |
AU3549499A (en) | Telomerase-associated proteins | |
AU2576501A (en) | Protein kinase inhibitors | |
AU4281999A (en) | Peptide | |
AU2190801A (en) | Binding protein | |
AU4188500A (en) | Protein c derivatives | |
AU9105698A (en) | Rab proteins | |
AU2591299A (en) | Human protein kinase c inhibitor | |
AU2590099A (en) | Protein folding inhibitors | |
AU1751801A (en) | Protein c derivatives | |
AU6000698A (en) | Proteins | |
AU2136401A (en) | P450rai-2 and related proteins | |
AU1881200A (en) | Novel proteins | |
AU2538899A (en) | Protein kinase c | |
AU2001244863A1 (en) | Apoptin-associating protein | |
AU2002239747A1 (en) | Cystoskeleton-associated proteins | |
AU1540701A (en) | Novel protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |